| scholarly article | Q13442814 |
| P2093 | author name string | Hamilton SR | |
| Rashid A | |||
| Issa JP | |||
| Shen L | |||
| Morris JS | |||
| P2860 | cites work | Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 |
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| Lessons from hereditary colorectal cancer | Q28131788 | ||
| CpG-rich islands and the function of DNA methylation | Q28131800 | ||
| The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis | Q28138414 | ||
| Mutations in the p53 gene occur in diverse human tumour types | Q28249770 | ||
| APC mutations occur early during colorectal tumorigenesis | Q28274764 | ||
| Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma | Q29615026 | ||
| Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer | Q29615066 | ||
| Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines | Q29620526 | ||
| Cancer genetics: tumor suppressor meets oncogene. | Q33533777 | ||
| TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis | Q33828926 | ||
| COBRA: a sensitive and quantitative DNA methylation assay | Q34630070 | ||
| Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype | Q34975498 | ||
| Epigenetic silencing of RNA polymerase I transcription: a role for DNA methylation and histone modification in nucleolar dominance | Q35188735 | ||
| Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas | Q35355359 | ||
| Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections | Q35764415 | ||
| Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island | Q38303631 | ||
| The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation | Q38331684 | ||
| Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors | Q40927952 | ||
| DNA methylation errors and cancer. | Q41000721 | ||
| X chromosome imprinting and inactivation in the early mammalian embryo | Q41196156 | ||
| Alterations in DNA methylation: a fundamental aspect of neoplasia | Q41617101 | ||
| Microsatellite instability: the mutator that mutates the other mutator | Q44602861 | ||
| Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer | Q45345220 | ||
| Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1 | Q50893078 | ||
| Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa | Q52892421 | ||
| Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia | Q56418625 | ||
| Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis | Q57240066 | ||
| Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia | Q57240085 | ||
| Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers | Q71167724 | ||
| Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers | Q71729088 | ||
| Genomic instability occurs in colorectal carcinomas but not in adenomas | Q72649470 | ||
| Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon | Q72781919 | ||
| Microsatellite instability in colorectal adenomas | Q73309470 | ||
| Association between CpG island methylation and microsatellite instability in colorectal cancer | Q73622839 | ||
| Association of K-ras mutations with p16 methylation in human colon cancer | Q77374977 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | CpG island | Q1138360 |
| P304 | page(s) | 1129-1135 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | CpG island methylation in colorectal adenomas | |
| P478 | volume | 159 |
| Q33914431 | A beta-mixture model for dimensionality reduction, sample classification and analysis |
| Q39751557 | A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer |
| Q35584153 | A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy |
| Q39560142 | AP1B plays an important role in intestinal tumorigenesis with the truncating mutation of an APC gene |
| Q54719199 | Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. |
| Q30494652 | Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model |
| Q35605612 | Aberrant crypt foci as microscopic precursors of colorectal cancer |
| Q37214832 | Aberrant crypt foci as precursors in colorectal cancer progression |
| Q38166581 | Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer |
| Q35075702 | Aberrant methylation of gene associated CpG sites occurs in borderline personality disorder |
| Q37347838 | Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors |
| Q37683456 | Age-related epigenetic drift in the pathogenesis of MDS and AML. |
| Q54690884 | Analysis of allelic imbalances at multiple cancer-related chromosomal loci and microsatellite instability within the same tumor using a single tumor gland from colorectal carcinomas. |
| Q28757763 | Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas |
| Q89843964 | Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies |
| Q36619262 | Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy. |
| Q46365032 | BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer |
| Q35369905 | BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma |
| Q60046390 | Biomarkers in colorectal cancer: Current clinical utility and future perspectives |
| Q40007314 | Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. |
| Q36172680 | CIMP and colon cancer gets more complicated |
| Q39258008 | Case-control study of candidate gene methylation and adenomatous polyp formation |
| Q36699559 | Classification of colorectal cancer based on correlation of clinical, morphological and molecular features |
| Q54551065 | Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers. |
| Q48500704 | Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection |
| Q35747320 | Concordant CpG island methylation in hyperplastic polyposis. |
| Q54627726 | CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer. |
| Q35748049 | CpG island methylation in aberrant crypt foci of the colorectum |
| Q36854134 | CpG island methylation in familial colorectal cancer patients not fulfilling the Amsterdam criteria |
| Q83365535 | CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer |
| Q35807863 | CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations |
| Q61865606 | DNA methylation changes in ex-adenoma carcinoma of the large intestine |
| Q83767772 | DNA methylation defects in sporadic and hereditary colorectal cancer |
| Q37687919 | DNA methylation markers in colorectal cancer |
| Q35785652 | DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps |
| Q37776026 | DNA methylation profiling in cancer |
| Q92405306 | Dysfunctional epigenetic aging of the normal colon and colorectal cancer risk |
| Q35646086 | Emerging diet-related surrogate end points for colorectal cancer: UK Food Standards Agency diet and colonic health workshop report |
| Q28087759 | Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer |
| Q35118511 | Epidemiologic considerations to assess altered DNA methylation from environmental exposures in cancer. |
| Q84699545 | Epigenetic Biomarkers |
| Q33235330 | Epigenetic alterations in RASSF1A in human aberrant crypt foci |
| Q44429799 | Epigenetic and genetic alterations in duodenal carcinomas are distinct from biliary and ampullary carcinomas. |
| Q44938471 | Epigenetic events and protection from colon cancer in New Zealand. |
| Q35782660 | Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer |
| Q36529734 | Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma |
| Q36081553 | Epigenetics and colorectal cancer |
| Q45362780 | Evaluation of tumor suppressor gene expressions and aberrant methylation in the colon of cancer-induced rats: a pilot study |
| Q39182132 | Expression of Type 2 Orexin Receptor in Human Endometrium and Its Epigenetic Silencing in Endometrial Cancer |
| Q34416852 | Field cancerization in the colon: a role for aberrant DNA methylation? |
| Q35542190 | Folate, DNA methylation and colo-rectal cancer |
| Q35791305 | Frequent CpG island methylation in serrated adenomas of the colorectum |
| Q35118470 | Genetic and Epigenetic Mosaicism in Cancer Precursor Tissues |
| Q37126768 | Genetic and epigenetic changes in aberrant crypt foci and serrated polyps |
| Q57977995 | Genetics supersedes epigenetics in colon cancer phenotype |
| Q64119959 | Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer |
| Q33836026 | Genomic and epigenetic instability in colorectal cancer pathogenesis |
| Q35029017 | Hypermethylation pathways to colorectal cancer. Implications for prevention and detection |
| Q53542026 | Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumors. |
| Q58104493 | Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway |
| Q47375648 | INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma |
| Q35594804 | INK4a-ARF alterations in liver cell adenoma |
| Q46967606 | INK4a-ARF alterations in liver cell adenoma |
| Q35194198 | Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas |
| Q37582033 | Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer |
| Q42241147 | Lack of Aberrant Methylation in an Adjacent Area of Left-Sided Colorectal Cancer |
| Q34225341 | Metastatic suppressor genes inactivated by aberrant methylation in gastric cancer |
| Q37620965 | Methods for genome-wide analysis of DNA methylation in intestinal tumors |
| Q54720252 | Methylation in p14(ARF) is frequently observed in colorectal cancer with low-level microsatellite instability. |
| Q36076356 | Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis |
| Q28243755 | Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders |
| Q36891683 | Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer |
| Q34358286 | Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer |
| Q95725436 | O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer |
| Q35761211 | Oesophageal squamous cell carcinoma may develop within a background of accumulating DNA methylation in normal and dysplastic mucosa |
| Q89636437 | Past, present, and future of genetic research in borderline personality disorder |
| Q30585819 | Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age |
| Q37733784 | Prognostic and predictive value of CpG island methylator phenotype in patients with locally advanced nonmetastatic sporadic colorectal cancer. |
| Q51603737 | Prognostic implications of CpG island hypermethylator phenotype in colorectal cancers |
| Q44981691 | Prolapse-related changes are a confounding factor in misdiagnosis of sessile serrated adenomas in the rectum |
| Q53364696 | Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia |
| Q37245289 | Promoter methylation in the genesis of gastrointestinal cancer |
| Q53337445 | Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer |
| Q24603535 | Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas |
| Q36144242 | Quantitative Analysis of Cancer-associated Gene Methylation Connected to Risk Factors in Korean Colorectal Cancer Patients |
| Q53343035 | Relationship between point gene mutation, chromosomal abnormality, and tumour suppressor gene methylation status in colorectal adenomas |
| Q26827208 | Serrated lesions of the colorectum: review and recommendations from an expert panel |
| Q46530603 | Serum methylation levels ofTAC1. SEPT9andEYA4as diagnostic markers for early colorectal cancers: a pilot study |
| Q33770826 | Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract. |
| Q92193162 | The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer |
| Q36383337 | The blues of P(16)INK(4a): aberrant promoter methylation and association with colorectal cancer in the Kashmir valley. |
| Q36656549 | The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening |
| Q38533166 | The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer |
| Q35749254 | The relationship between hypomethylation and CpG island methylation in colorectal neoplasia |
| Q35096122 | The role of the cyclin D1-dependent kinases in ErbB2-mediated breast cancer |
| Q35711210 | Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia |
| Q36556548 | p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer. |
Search more.